Saxenda vs Wegovy: Daily vs Weekly
Reviewed by the MaxLife operations team. Labels, trials, prices and FDA status checked November 2026.
Key Takeaways
- Saxenda's label says to stop if an adult hasn't lost at least 4% of their weight after 16 weeks; Wegovy's label has no such cutoff.
- Of the two, only Wegovy is also approved to lower the risk of heart attack and stroke in adults with heart disease, and to treat MASH liver disease.
- The Medicare GLP-1 Bridge covers Wegovy for eligible Part D members at $50 a month through 2027; Saxenda is not included.

Saxenda® (liraglutide) and Wegovy® (semaglutide) are both Novo Nordisk GLP-1 medicines approved for weight management, and the difference most people notice first is the schedule: Saxenda is injected once a day, Wegovy once a week. In STEP 8, the only trial that compared liraglutide vs semaglutide head to head for weight loss, adults lost an average of 15.8% of their body weight on weekly semaglutide at the Wegovy dose over 68 weeks, compared with 6.4% on daily liraglutide at the Saxenda dose. As of November 2026, Novo Nordisk is discontinuing Saxenda in the US, with last shipments to wholesalers in late January 2027, and FDA-approved generic liraglutide is available.
Saxenda vs Wegovy at a Glance
| Saxenda | Wegovy | |
|---|---|---|
| Medicine | Liraglutide | Semaglutide |
| How often | One injection a day | One injection a week (a daily pill also exists) |
| Full dose | 3 mg a day, from week 5 | 2.4 mg a week, from week 17 |
| Weight loss, head to head (STEP 8, 68 weeks) | 6.4% | 15.8% |
| Approved for | Weight management, adults and teens 12 and older | Weight management (adults and teens 12 and older), lowering heart risk, MASH liver disease |
| Status, November 2026 | Being discontinued in the US; generic liraglutide available | Available; no generic |
| Price, November 2026 | List price $1,349.02 | Self-pay pens $349 a month ($199 for a new patient's first two fills) |
Doses and uses come from the FDA labels for Saxenda and Wegovy, both updated in June 2026. Prices are Novo Nordisk's, checked November 2026.
Is Wegovy Stronger Than Saxenda?
Yes. In STEP 8, published in JAMA in 2022, 338 adults with obesity, or overweight and a weight-related condition, and without diabetes took either weekly semaglutide 2.4 mg or daily liraglutide 3 mg for 68 weeks, along with diet and activity counseling. Semaglutide led to 9.4 percentage points more weight loss on average. About 7 in 10 people on semaglutide lost at least 10% of their weight, compared with about 1 in 4 on liraglutide.
Head-to-head trial
STEP 8: weekly semaglutide vs daily liraglutide
The only trial that put the two medicines side by side, at the doses sold as Wegovy® and Saxenda®.
Average weight lost at 68 weeks
Semaglutide 2.4 mg once a week (Wegovy dose)15.8%
Liraglutide 3 mg once a day (Saxenda dose)6.4%
Placebo1.9%
People who lost 10% or more
Semaglutide 2.4 mg once a week (Wegovy dose)70.9%
Liraglutide 3 mg once a day (Saxenda dose)25.6%
People who lost 15% or more
Semaglutide 2.4 mg once a week (Wegovy dose)55.6%
Liraglutide 3 mg once a day (Saxenda dose)12.0%
People who lost 20% or more
Semaglutide 2.4 mg once a week (Wegovy dose)38.5%
Liraglutide 3 mg once a day (Saxenda dose)6.0%
Who stopped: 27.6% of people stopped liraglutide early, compared with 13.5% on semaglutide. Stomach side effects were about as common with both (82.7% and 84.1%).
Source: STEP 8, Rubino and colleagues, JAMA, 2022: 338 adults with obesity, or overweight and a weight-related condition, without diabetes, at 19 US sites; open-label between the two medicines; everyone also had diet and activity counseling. These results are for the brand-name doses studied and have not been shown for compounded semaglutide.
Each medicine's own placebo-controlled trial points the same way. In SCALE, adults without diabetes taking Saxenda lost 7.4% of their body weight over 56 weeks, compared with 3.0% on placebo, by the Saxenda label's analysis. In STEP 1, adults taking Wegovy lost 14.9% over 68 weeks, compared with 2.4%.
Two things to keep in mind. STEP 8 was open-label between the two medicines, so people knew which one they were taking. And Wegovy's label now also allows a higher 7.2 mg weekly dose for some adults, sold as Wegovy HD, which our Ozempic vs Wegovy guide covers. All of these results are for the brand-name medicines studied.
Liraglutide vs Semaglutide: Why Is One Daily and One Weekly?
Both medicines act like GLP-1, a gut hormone that lowers appetite, and both were developed by Novo Nordisk. The difference is how long each one lasts in the body. According to the labels, liraglutide has a half-life of about 13 hours, so Saxenda is taken every day. Semaglutide's half-life is about one week, so Wegovy is taken once a week. That one fact shapes daily life on each:
| Saxenda (daily) | Wegovy (weekly) | |
|---|---|---|
| Injections a year | 365 | 52 |
| How you start | 0.6 mg a day, up 0.6 mg each week | 0.25 mg a week, up one step every 4 weeks |
| Full dose | 3 mg a day from week 5 | 2.4 mg a week from week 17 (1.7 mg is the other option) |
| A missed dose | Skip it and take the next one as planned; after more than 3 days, restart at 0.6 mg | Take it if the next dose is more than 2 days away, otherwise skip it; after 2 or more missed weeks, restart lower |
| Pens | A multi-dose pen with a new pen needle each day (needles sold separately) | Single-dose pens, or one pen that holds 4 weekly doses |
Three more differences come from the labels:
- The 16-week check. Saxenda's label tells prescribers to check an adult's weight after 16 weeks and stop Saxenda if they haven't lost at least 4% of their starting weight, because more time is unlikely to help. Wegovy's label has no such cutoff.
- The slow start. Wegovy takes 16 weeks to reach its usual dose, compared with 4 weeks of steps for Saxenda. Both labels build in these steps to make stomach side effects less likely.
- After the last dose. Semaglutide stays in the blood for about 5 to 7 weeks after the last Wegovy shot, so its label says to stop at least 2 months before a planned pregnancy. Saxenda's label says to stop it once a pregnancy is known.
Saxenda vs Wegovy Side Effects
Both cause the same kinds of side effects, mostly in the stomach. Nausea, diarrhea, constipation and vomiting are the most common on both labels. In their separate trials, nausea affected 39% of people on Saxenda (14% on placebo) and 44% on Wegovy (16% on placebo). In STEP 8, where the two were compared directly, stomach side effects were about as common with both, but more than twice as many people stopped liraglutide early.
Both labels carry the same boxed warning about thyroid C-cell tumors: don't use either if you or a family member has had medullary thyroid carcinoma, or if you have MEN 2. Both also warn about pancreatitis, gallbladder problems, low blood sugar when used with insulin or a sulfonylurea, a faster heart rate, kidney problems from dehydration, serious allergic reactions, and food entering the lungs during anesthesia or deep sedation. Wegovy's label adds eye complications in people with type 2 diabetes. In February 2026, both labels removed their section on suicidal behavior and ideation.
Nausea or other stomach upset is also the side effect MaxLife members write to us about most. Our guide to GLP-1 nausea and constipation covers what helps.
Who Is Each One Approved For?
Both are approved, with a reduced-calorie diet and more physical activity, for adults with obesity, adults with overweight and at least one weight-related condition such as high blood pressure, and teens 12 and older with obesity. Saxenda's teen approval also requires a body weight over 132 lb (60 kg).
Wegovy has two more approved uses. It lowers the risk of heart attack, stroke and death from heart disease in adults with heart disease and obesity or overweight: in the SELECT trial, 6.5% of people on Wegovy had one of those events, compared with 8.0% on placebo. It is also approved, under accelerated approval, for MASH, a liver disease, with moderate to advanced scarring. Saxenda is approved for weight management only. Wegovy also comes as a daily pill for adults; see Wegovy pill vs injection.
Why Is Saxenda Being Discontinued?
Novo Nordisk gives notice on the Saxenda website that it is discontinuing Saxenda in the US, with last shipments to wholesalers in late January 2027. It says fewer people use Saxenda now that other medicines are available, and that the decision is not the result of any safety or quality concern. The FDA's drug shortage database lists Saxenda as available until then.
If you take Saxenda, don't stop on your own. Before your supply runs out, ask your prescriber whether to move to generic liraglutide, taken once a day like Saxenda, or to a weekly medicine such as Wegovy. If you're weighing tirzepatide (Zepbound®) instead, see our tirzepatide vs Saxenda comparison.
Is There a Generic Saxenda or Wegovy?
There is a generic Saxenda, but no generic Wegovy. The FDA approved the first generic liraglutide, referencing Victoza®, the diabetes brand, on December 23, 2024, and the first generic referencing Saxenda, for weight management, on August 27, 2025. As of November 2026, no generic semaglutide has final FDA approval. Our page Is there a generic Ozempic? explains what "generic" means and where semaglutide stands.
Is Saxenda More Expensive Than Wegovy?
For people paying cash, brand Saxenda usually costs more. As of November 2026:
- Saxenda: NovoCare lists a list price of $1,349.02, with a savings offer for eligible patients (as little as $25, or up to $200 off a prescription, for up to 12 months). Generic liraglutide prices vary by pharmacy, so ask yours for the cash price.
- Wegovy: Novo Nordisk's NovoCare Pharmacy sells the pens self-pay for $199 for each of a new patient's first two monthly fills (through December 31, 2026), then $349 a month for any dose up to 2.4 mg, or $399 for Wegovy HD. The pill costs $149 to $299 a month.
- Medicare: since July 1, 2026, the Medicare GLP-1 Bridge has covered Wegovy for eligible Part D members, who pay $50 a month, through December 31, 2027. Saxenda is not included. Our Medicare GLP-1 Bridge guide explains who qualifies.
With private insurance, coverage for weight loss varies, and Wegovy's heart and liver uses can sometimes be covered when weight-loss drugs are not. Our semaglutide cost guide works out a full year of each option.
Compounded semaglutide is a lower-cost cash route some people consider. It is prepared by a licensed pharmacy for one patient's prescription and is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality. It is not a generic, and the trial results above have not been shown for it. Through MaxLife, compounded semaglutide costs $89 a month, flat and all-inclusive, the same price at every dose, with no membership fee. MaxLife offers compounded semaglutide and tirzepatide only, not Saxenda, Wegovy or liraglutide, so if your insurance covers Wegovy, that may cost you less.
Can You Switch From Saxenda to Wegovy?
Yes, with your prescriber. Both labels say not to use either one with another GLP-1 medicine, so you don't take them together. There is no dose conversion: Wegovy's label starts everyone at 0.25 mg a week and steps up every 4 weeks, even after months on Saxenda 3 mg. Ask your prescriber when to take your last Saxenda dose and your first Wegovy dose.
If you move to MaxLife from another program, you send proof of your current prescription and the date of your last injection, and a licensed provider decides whether compounded semaglutide is right for you and at what dose. Compounded semaglutide comes in a vial, so you draw each dose with a syringe. The number of units depends on the vial's strength: follow the label on the vial you have and your prescriber's instructions, and draw each dose when you take it rather than filling syringes ahead of time.
Saxenda or Wegovy: Which Fits You?
"Which one is better?" is a question people often ask us before they start. For the brand medicines, the trial data give a clear answer on weight loss, and the rest depends on your situation:
- You want the most weight loss with the fewest injections: the head-to-head results favor Wegovy.
- You have heart disease, or MASH liver disease, along with excess weight: of the two, only Wegovy is approved for those uses.
- You're doing well on Saxenda and like the daily routine: generic liraglutide keeps the same medicine after the brand leaves the market.
- You have a teen with obesity: both are approved from age 12, and the choice belongs with a pediatric specialist.
- You pay cash: compare generic liraglutide at your pharmacy, Wegovy self-pay and compounded semaglutide.
How we made this page: we researched it from the sources listed below. The MaxLife operations team reviews every page before it goes live, and a licensed clinician also reviews our medical articles.
Frequently Asked Questions
Compounded Semaglutide: $89/mo Flat, All-Inclusive
MaxLife compounded semaglutide: $89 a month, flat. All-inclusive, no membership fee, the same price at every dose. A licensed provider decides.
Check Your EligibilityThis article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary. Pricing, insurance coverage, and compounding regulations described here are subject to change; verify current details with your insurance provider, the manufacturer, or your prescriber before making treatment decisions. Compounded medications are not FDA-approved.
Sources
- Saxenda (liraglutide) injection: FDA prescribing information, Medication Guide and Instructions for Use, Novo Nordisk (DailyMed, version of June 2026)
- Wegovy (semaglutide) injection and tablets: FDA prescribing information, Novo Nordisk (DailyMed, version of June 2026)
- Rubino DM et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA, 2022
- Pi-Sunyer X et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE). New England Journal of Medicine, 2015
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021
- Novo Nordisk: Saxenda discontinuation notice, saxenda.com (checked November 2026)
- FDA Drug Shortages database: liraglutide injection entries (checked November 2026)
- FDA: FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes (December 23, 2024)
- FDA: 2025 First Generic Drug Approvals (liraglutide injection referencing Saxenda, August 27, 2025)
- NovoCare: Saxenda list price and savings offer (checked November 2026)
- NovoCare Pharmacy: Wegovy self-pay prices (checked November 2026)
- CMS: Medicare GLP-1 Bridge, information for providers (checked November 2026)

Tirzepatide (Zepbound) vs Saxenda: 7 Differences to Know
August 20, 20267 min

Ozempic vs Wegovy: Same Drug, Different Doses and Uses
November 14, 202610 min

Semaglutide Cost: Wegovy, Ozempic and Compounded Prices Per Month
August 20, 20269 min

Wegovy Alternative: 5 Options for Lower Cost or More Weight Loss
August 18, 20268 min
